The audit aims to provide real-world benchmarks and enable patients, providers and commissioners to compare clinical outcomes and key care processes at different sites. This will enable informed decision-making and patient choice.
- AMD remains the leading cause of sight impairment, despite new treatment options
- It is estimated to affect 600,000 people in the UK with 39,800 patients developing “wet” AMD each year
- The number of people with AMD is expected to rise by an alarming 60% by 2035
- Prompt diagnosis and continued maintenance treatments for AMD are vital to maintaining vision and reducing irrecoverable visual loss
- The audit is in its first year of operation and aims to improve the care patients undergoing AMD treatment receive.
- The first data analysis on extracted data covering from 01 April 2010 to 31 March 2022. The first analysis of data from the National AMD Audit is expected to be available by the end of November 2022.
- Data as set out in the AMD Audit Data Set is collected as a by-product of routine clinical care using Electronic Medical Records (EMR) systems in Hospital Eye Services.
- The next data extraction will take place in May 2023.